Early Biomarker Kidney Injury Assessment After Acumen Directed Fluid Management in Cardiac Surgery
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorUniversity of Maryland, Baltimore
About this trial
This study is to assess the benefits of goal-directed fluid management with ACUMEN in cardiac surgical patients and its impact on cardiac surgery-induced kidney injury.
Eligibility criteria
Qualifiers
Adult patients undergoing cardiopulmonary bypass
Procedure coronary artery bypass grafting, aortic valve replacement, or both
Disqualifiers
Patients < 18 years old
Emergent surgery
Preoperative kidney disease (Cr > 2.0 or on renal replacement therapy)
Ejection fraction < 40%
Trial design
Treatments tested in this trial
- Goal Directed Fluid Therapy
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov